NovaScan participated in a poster session at the 2017 American College of Mohs Surgeons Annual Meeting, where the company presented A Rapid Method for Detecting Non-Melanoma Skin Cancer in Mohs Micrographic Surgery. The poster, which demonstrates how NovaScan can...

NovaScan Senior Scientist John Shell, Ph.D. has been selected to present in a poster session at a Special Topics Conference on Healthcare Innovations and Point of Care Technologies, co-sponsored by the National Institute of Health and IEEE. Dr. Shell will be...

PROPEL, dedicated to increasing the number and success rate of early-stage life sciences companies in Illinois, announced on April 19 at the 2016 Innovation Showcase on Day 1 of iBIO IndEx that NovaScan won the 2016 PROPEL Business Plan Competition. Over 300 community...

From 2010-2015, NovaScan recieved National Science Foundation SBIR awards for Phase I, Phase Ia, Phase II and Phase IIb. ($2,291,925 — including investor match)

On a Thursday afternoon in November, a pea-sized lymph node from a mastectomy patient is brought into the crowded office of Dr. Gerald Smith, laboratory medical director at Aurora Sinai Medical Center. While the patient remains in the operating room, Smith freezes,...

A local inventor is on the verge of groundbreaking breast cancer technology. https://www.youtube.com/watch?v=cWhf7sZuYiE

Cancer-scanning device detects residual cancer cells post-surgery—Biotech’s future. Video made by National Science Foundation (NSF). https://www.youtube.com/watch?v=VH_Ib2pVLSg